Managed Access Programs for INC424, Ruxolitinib

Clinical trial NCT04745637 · AVAILABLE

Trial details

NCT number: NCT04745637
Sponsor: Novartis Pharmaceuticals
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Primary Myelofibrosis (PMF)Post Polycythemia Myelofibrosis (PPV MF)Thrombocythemia Myelofibrosis (PET-MF)Severe/Very Severe COVID-19 Illness Polycythemia Vera (PV)Steroid Refractory Acute Graft Versus Host Disease (SR aGVHD)Steroid Refractory Chronic Graft Versus Host Disease (SR cGVHD)

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.